Literature DB >> 4355215

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

H Strander, K Cantell, G Carlström, P A Jakobsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4355215     DOI: 10.1093/jnci/51.3.733

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

1.  Production of human lymphoblastoid interferon.

Authors:  H Strander; K E Mogensen; K Cantell
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

2.  Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas.

Authors:  D Neumann-Haefelin; R Sundmacher; B Sauter; H E Karges; K F Manthey
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

Review 3.  Interferon in 1987: the half full glass.

Authors:  S E Krown
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 4.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

5.  Inhibition of herpes simplex virus type 2-induced biochemical transformation by interferon.

Authors:  F Rapp; Y Nishiyama
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

Review 6.  Does interferon cure cancer?

Authors:  K Sikora
Journal:  Br Med J       Date:  1980-09-27

Review 7.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

8.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

9.  Electrophoretically pure mouse interferon exerts multiple biologic effects.

Authors:  I Gresser; J De Maeyer-Guignard; M G Tovey; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

Authors:  T H Bacon; A de Vere-Tyndall; D A Tyrrell; A M Denman; B M Ansell
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.